BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 17198928)

  • 1. Advances in carnitine in chronic uremia.
    Guarnieri G; Biolo G; Vinci P; Massolino B; Barazzoni R
    J Ren Nutr; 2007 Jan; 17(1):23-9. PubMed ID: 17198928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnitine metabolism in uremia.
    Guarnieri G; Situlin R; Biolo G
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S63-7. PubMed ID: 11576925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine and hemodialysis.
    Bellinghieri G; Santoro D; Calvani M; Mallamace A; Savica V
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S116-22. PubMed ID: 12612967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine replacement in end-stage renal disease and hemodialysis.
    Calvani M; Benatti P; Mancinelli A; D'Iddio S; Giordano V; Koverech A; Amato A; Brass EP
    Ann N Y Acad Sci; 2004 Nov; 1033():52-66. PubMed ID: 15591003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer aspects of carnitine metabolism in uremia.
    Savica V; Calvani M; Benatti P; Santoro D; Monardo P; Mallamace A; Savica R; Bellinghieri G
    Semin Nephrol; 2006 Jan; 26(1):52-5. PubMed ID: 16412827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysis-related carnitine disorder.
    Hedayati SS
    Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-carnitine supplementation in the dialysis population: are Australian patients missing out?
    Reuter SE; Faull RJ; Evans AM
    Nephrology (Carlton); 2008 Feb; 13(1):3-16. PubMed ID: 18199095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial function, energy provision, and carnitine deficiency in experimental uremia.
    Reddy V; Bhandari S; Seymour AM
    J Am Soc Nephrol; 2007 Jan; 18(1):84-92. PubMed ID: 17182887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carnitine metabolism in chronic kidney failure].
    Fiorini F; Patrone E; Castellucci A
    Clin Ter; 1992 Jan; 140(1 Pt 2):31-4. PubMed ID: 1559320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. History of L-carnitine: implications for renal disease.
    Matera M; Bellinghieri G; Costantino G; Santoro D; Calvani M; Savica V
    J Ren Nutr; 2003 Jan; 13(1):2-14. PubMed ID: 12563618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of L-carnitine on respiratory function tests in children undergoing chronic hemodialysis.
    Kavukçu S; Türkmen M; Salman S; Onvural B; Oktay G; Karaman O; Cevik NT
    Turk J Pediatr; 1998; 40(1):79-84. PubMed ID: 9673532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimyopathic effects of carnitine and nicotine.
    Laviano A; Meguid MM; Guijarro A; Muscaritoli M; Cascino A; Preziosa I; Molfino A; Rossi Fanelli F
    Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):442-8. PubMed ID: 16778574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-Carnitine: therapeutic applications of a conditionally-essential amino acid.
    Kelly GS
    Altern Med Rev; 1998 Oct; 3(5):345-60. PubMed ID: 9804680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-carnitine supplementation in dialysis patients: does the evidence justify its use?
    Steinman TI
    Semin Dial; 2005; 18(1):1-2. PubMed ID: 15663752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic potential of carnitine in cardiovascular disorders.
    Pepine CJ
    Clin Ther; 1991; 13(1):2-21; discussion 1. PubMed ID: 2029724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Debate forum: levocarnitine therapy is rational and justified in selected dialysis patients.
    Schreiber BD
    Blood Purif; 2006; 24(1):128-39. PubMed ID: 16361853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of L-carnitine administration on erythropoietin use in thalassemic minor haemodialysis patients.
    Di Iorio BR; Guastaferro P; Cillo N; Cucciniello E; Bellizzi V
    Nephrol Dial Transplant; 2007 Mar; 22(3):954-5; author reply 955-6. PubMed ID: 17132710
    [No Abstract]   [Full Text] [Related]  

  • 19. Carnitine in metabolic disease: potential for pharmacological intervention.
    Arduini A; Bonomini M; Savica V; Amato A; Zammit V
    Pharmacol Ther; 2008 Nov; 120(2):149-56. PubMed ID: 18793670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein and energy: recommended intake and nutrient supplementation in chronic dialysis patients.
    Ikizler TA
    Semin Dial; 2004; 17(6):471-8. PubMed ID: 15660578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.